Glenmede Disciplined U.S. Small Cap Equity Portfolio GQSCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$19.53  /  −0.05%
  • Fund Size$12.0M
  • Adjusted Expense Ratio0.850%
  • Net Expense Ratio0.850%
  • Fee Level: DistributionBelow Average
  • Share Class TypeNo Load
  • Morningstar CategorySmall Value
  • Equity Style Box (Funds)Small Value
  • Minimum Initial Investment$0
  • Investment StatusOpen
  • TTM Yield0.33%
  • Turnover Ratio92%

Morningstar’s Analysis GQSCX

Will GQSCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Glenmede Disciplined US Small Cap Eq Ptf holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GQSCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings9.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

10x Genomics Inc Ordinary Shares - Class A

1.74122,076
Healthcare

CareDx Inc

0.9667,275
Healthcare

Recursion Pharmaceuticals Inc Class A

0.8660,410
Healthcare

Coursera Inc

0.8660,324
Consumer Defensive

Green Plains Inc

0.8560,059
Basic Materials

PRA Group Inc

0.8559,971
Financial Services

Covista Inc

0.8459,267
Consumer Defensive

HealthStream Inc

0.8459,182
Healthcare

AMN Healthcare Services Inc

0.8459,114
Healthcare

MiMedx Group Inc

0.8358,390
Healthcare

Sponsor Center